AFIFA, SABILA NAURA (2022) COST EFFECTIVENESS ANALYSIS PADA KEJADIAN DRUG RELATED PROBLEMS PASIEN GAGAL JANTUNG KONGESTIF DI RUMAH SAKIT UMUM DAERAH BANYUMAS. S1 thesis, UNIVERSITAS MUHAMMADIYAH PURWOKERTO.

Preview	Text Sabila Naura Afifa_Cover.pdf Download (1MB) | Preview
Preview	Text Sabila Naura Afifa_BAB 1.pdf Download (792kB) | Preview
Preview	Text Sabila Naura Afifa_BAB 2.pdf Download (1MB) | Preview
	Text Sabila Naura Afifa_BAB 3.pdf Restricted to Registered users only Download (1MB)
	Text Sabila Naura Afifa_BAB 4.pdf Restricted to Registered users only Download (906kB)
	Text Sabila Naura Afifa_BAB 5.pdf Restricted to Registered users only Download (760kB)
Preview	Text Sabila Naura Afifa_DAFTAR PUSTAKA.pdf Download (659kB) | Preview
	Text Sabila Naura Afifa_Lampiran.pdf Restricted to Registered users only Download (1MB)

Abstract

Background: The incidence of Drug Related Problems (DRPs) in heart failure patients can lead to increased costs. The incidence of DRPs in Patients with Congestif Heart Failure (CHF) can come from dosage errors, improper drug selection, drug interactions, ROTD, and other causes. The incidence of CONGESTIVE HEART FAILURE DRPs has a tremendous economic impact, expected to increase every year. This study aims to determine the incidence of DRPs in the therapy of CHF patients at the Banyumas Regional General Hospital and conduct pharmacoeconomic analysis based on the incidence of DRPs and non-DRPs. The method used for pharmacoeconomic analysis uses ICER. Method: This research is a quantitative research in the form of retrospective cross-sectional analysis. The subjects of the study were all inpatients diagnosed with congestive heart failure at the Banyumas Regional General Hospital. Result: This research showed that there were 11 types of CHF patient therapy regimens at banyumas regional general hospital and diuretic loops that were most often used (21.59%). The highest therapeutic effectiveness was found in the anti-angina therapy regimen (92.30%). The total direct cost of CHF DRPs patients is Rp. 7.321.318 and non-DRPs are Rp. 170.698.163. The incidence of DRPs in CHF patients with drug interactions was 2 accident, drug overdose was 1 accident, drug selection error and overdose was 0 accident. Conclusion: The outcomes obtained showed that non-DRPs CHF patients (88,46%) had better scores than CHF patients with incidence of DRPs (66,67%). The ICER value obtained by comparing the cost-effectiveness and outcomes of CHF DRPs and non-DRPs patients was Rp. 7.496.114.

Dosen Pembimbing:	SETIAWAN, DIDIK and PUTRI, IRSALINA NURUL | nidn0627078301, nidn0605069203
Item Type:	Thesis (S1)
Uncontrolled Keywords:	Congestif Heart Failure, Drug Related Problems, Pharmacoeconomics, ICER
Subjects:	R Medicine > RS Pharmacy and materia medica
Divisions:	Fakultas Farmasi > Farmasi S1
Depositing User:	wulan
Date Deposited:	19 Oct 2022 01:54
Last Modified:	15 May 2024 01:17
URI:	http://repository.ump.ac.id/id/eprint/14518

Actions (login required)

View Item